-
1
-
-
0242658912
-
Opioid therapy for chronic pain
-
Ballantyne JC, Mao J: Opioid therapy for chronic pain. N Engl J Med 2003; 349:1943-53
-
(2003)
N Engl J Med
, vol.349
, pp. 1943-1953
-
-
Ballantyne, J.C.1
Mao, J.2
-
2
-
-
33645509700
-
Opioid-induced hyperalgesia: A qualitative systematic review
-
Angst MS, Clark JD: Opioid-induced hyperalgesia: A qualitative systematic review. ANESTHESIOLOGY 2006; 104:570-87
-
(2006)
ANESTHESIOLOGY
, vol.104
, pp. 570-587
-
-
Angst, M.S.1
Clark, J.D.2
-
3
-
-
0019524261
-
Intrathecal high dose morphine produces hyperalgesia in the rat
-
Woolf CJ: Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res 1981; 491-5
-
(1981)
Brain Res
, pp. 491-495
-
-
Woolf, C.J.1
-
4
-
-
0022558928
-
High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: Clinical and theoretic implications
-
Yaksh TL, Harty GJ, Onofrio BM: High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: Clinical and theoretic implications. ANESTHESIOLOGY 1986; 64:590-7
-
(1986)
ANESTHESIOLOGY
, vol.64
, pp. 590-597
-
-
Yaksh, T.L.1
Harty, G.J.2
Onofrio, B.M.3
-
5
-
-
0033957306
-
Antagonists of excitatory opioid receptor function enhances morphine's analgesic potency and attenuate opioid tolerance/dependence liability
-
Crain SM, Shen K-F: Antagonists of excitatory opioid receptor function enhances morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000; 84:121-31
-
(2000)
Pain
, vol.84
, pp. 121-131
-
-
Crain, S.M.1
Shen, K.-F.2
-
6
-
-
4644233594
-
Antinociceptive and nociceptive actions of opioids
-
Ossipov MH, Lai J, King T, Vanderah TW, Malan TP, Hruby VJ, Porreca F: Antinociceptive and nociceptive actions of opioids. J Neurobiol 2004; 61:126-48
-
(2004)
J Neurobiol
, vol.61
, pp. 126-148
-
-
Ossipov, M.H.1
Lai, J.2
King, T.3
Vanderah, T.W.4
Malan, T.P.5
Hruby, V.J.6
Porreca, F.7
-
7
-
-
0037454943
-
Opioid-induced hyperalgesia: Abnormal or normal pain?
-
simonnet G, Rivat C: Opioid-induced hyperalgesia: Abnormal or normal pain? Neuroreport 2003; 14:1-7
-
(2003)
Neuroreport
, vol.14
, pp. 1-7
-
-
simonnet, G.1
Rivat, C.2
-
8
-
-
33845945382
-
Glia as the "bad guys": Implications for improving clinical pain control and the clinical utility of opioids
-
Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF: Glia as the "bad guys": Implications for improving clinical pain control and the clinical utility of opioids. Brain Behav immun 2007; 21:131-46
-
(2007)
Brain Behav immun
, vol.21
, pp. 131-146
-
-
Watkins, L.R.1
Hutchinson, M.R.2
Ledeboer, A.3
Wieseler-Frank, J.4
Milligan, E.D.5
Maier, S.F.6
-
9
-
-
0022647610
-
Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat
-
Yoburn BC, Cohen AH, Inturrisi CE: Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat. J Pharmacol Exp Ther 1986; 237:126-30
-
(1986)
J Pharmacol Exp Ther
, vol.237
, pp. 126-130
-
-
Yoburn, B.C.1
Cohen, A.H.2
Inturrisi, C.E.3
-
10
-
-
34250168639
-
Nociception increases during opioid infusion in opioid receptor triple knock-out mice
-
Juni A, Klein G, Pintar JE, Kest B: Nociception increases during opioid infusion in opioid receptor triple knock-out mice. Neuroscience 2007; 147: 439-44
-
(2007)
Neuroscience
, vol.147
, pp. 439-444
-
-
Juni, A.1
Klein, G.2
Pintar, J.E.3
Kest, B.4
-
11
-
-
32644468581
-
Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: Evidence for multiple diverse hyperalge- sic systems
-
Juni A, Klein G, Kest B: Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: Evidence for multiple diverse hyperalge- sic systems. Brain Res 2006; 1070:35-44
-
(2006)
Brain Res
, vol.1070
, pp. 35-44
-
-
Juni, A.1
Klein, G.2
Kest, B.3
-
12
-
-
43949130709
-
Sex differences in hyperalgesia during morphine infusion: Effect of gonadectomy and estrogen treatment
-
Juni A, Klein G, Kowalczyk B, Ragnauth A, Kest B: Sex differences in hyperalgesia during morphine infusion: Effect of gonadectomy and estrogen treatment. Neuropharmacology 2008; 54:1264-70
-
(2008)
Neuropharmacology
, vol.54
, pp. 1264-1270
-
-
Juni, A.1
Klein, G.2
Kowalczyk, B.3
Ragnauth, A.4
Kest, B.5
-
13
-
-
39749119900
-
Morphine-6-glucuronide (M6G) for postoperative pain relief
-
Dahan A, van Dorp E, Smith T, Yassen A: Morphine-6-glucuronide (M6G) for postoperative pain relief. Eur J Pain 2007; 12:403-11
-
(2007)
Eur J Pain
, vol.12
, pp. 403-411
-
-
Dahan, A.1
van Dorp, E.2
Smith, T.3
Yassen, A.4
-
14
-
-
24144470762
-
Morphine-6-glucuronide: Actions and mechanisms
-
Kilpatrick GJ, Smith TW: Morphine-6-glucuronide: Actions and mechanisms. Med Res Rev 2005; 25:521-44
-
(2005)
Med Res Rev
, vol.25
, pp. 521-544
-
-
Kilpatrick, G.J.1
Smith, T.W.2
-
15
-
-
0030911452
-
Antisense mapping of MOR-1 in rats: Distinguishing between morphine and morphine-6/3-glucuronide antinociception
-
Rossi GC, Leventhal L, Pan YX, Cole J, Su W, Bodnar RJ, Pasternak GW: Antisense mapping of MOR-1 in rats: Distinguishing between morphine and morphine-6/3-glucuronide antinociception. J Pharmacol Exp Ther 1997; 281: 109-14
-
(1997)
J Pharmacol Exp Ther
, vol.281
, pp. 109-114
-
-
Rossi, G.C.1
Leventhal, L.2
Pan, Y.X.3
Cole, J.4
Su, W.5
Bodnar, R.J.6
Pasternak, G.W.7
-
16
-
-
0344237326
-
Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and uμ-opioid receptor deficient mice
-
Romberg R, Sarton E, Teppema L, Matthes HWD, Kiefer BL, Dahan A: Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and uμ-opioid receptor deficient mice. Br J Anaesth 2003; 91:682-70
-
(2003)
Br J Anaesth
, vol.91
, pp. 682-770
-
-
Romberg, R.1
Sarton, E.2
Teppema, L.3
Matthes, H.W.D.4
Kiefer, B.L.5
Dahan, A.6
-
17
-
-
0031667577
-
No heroin of morphine 6/3-glucuronide analgesia in uμ-opioid receptor knockout mice
-
Kitanaka N, Sora I, Kinsey S, Zeng Z, Uhl G: No heroin of morphine 6/3-glucuronide analgesia in uμ-opioid receptor knockout mice. Eur J Pharmacol 1998; 355:R1-3
-
(1998)
Eur J Pharmacol
, vol.355
-
-
Kitanaka, N.1
Sora, I.2
Kinsey, S.3
Zeng, Z.4
Uhl, G.5
-
18
-
-
60649110031
-
Efficacy and safety of morphine-6- glucuronide (M6G) for postoperative pain relief: A randomized, double-blind study
-
Smith TW, Binning AR, Dahan A: Efficacy and safety of morphine-6- glucuronide (M6G) for postoperative pain relief: A randomized, double-blind study. Eur J Pain 2009; 13:293-9
-
(2009)
Eur J Pain
, vol.13
, pp. 293-299
-
-
Smith, T.W.1
Binning, A.R.2
Dahan, A.3
-
19
-
-
34250357008
-
Morphine-6-glucuronide is analgesic in electrical pain model but hyperalgesic in heat pain model (abstract)
-
van Dorp E, Sarton E, Dahan A: Morphine-6-glucuronide is analgesic in electrical pain model but hyperalgesic in heat pain model (abstract). ANESTHESIOLOGY 2006; A495
-
(2006)
ANESTHESIOLOGY
-
-
van Dorp, E.1
Sarton, E.2
Dahan, A.3
-
20
-
-
0030458198
-
Effects of morphine-3-glucuronide on the antinoci- ceptive activity of peptide and nonpeptide opioid receptor agonists in mice
-
Bian JT, Bhargava HN: Effects of morphine-3-glucuronide on the antinoci- ceptive activity of peptide and nonpeptide opioid receptor agonists in mice. Peptides 1996; 17:1415-9
-
(1996)
Peptides
, vol.17
, pp. 1415-1419
-
-
Bian, J.T.1
Bhargava, H.N.2
-
21
-
-
0025006485
-
Morphine-3-glucuronide: A potent antagonist of morphine-analgesia
-
Smith MT, Watt JA, Cramond T: Morphine-3-glucuronide: A potent antagonist of morphine-analgesia. Life Sci 1990; 47:570-85
-
(1990)
Life Sci
, vol.47
, pp. 570-585
-
-
Smith, M.T.1
Watt, J.A.2
Cramond, T.3
-
22
-
-
18744390307
-
Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice
-
Clarke S, Czyzyk T, Ansonoff M, Nitsche JF, Hsu MS, Nilsson L, Larsson K, Borsodi A, Toth G, Hill R, Kitchen I, Pintar JE: Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice. Eur J Neurosci 2002; 16:1705-12
-
(2002)
Eur J Neurosci
, vol.16
, pp. 1705-1712
-
-
Clarke, S.1
Czyzyk, T.2
Ansonoff, M.3
Nitsche, J.F.4
Hsu, M.S.5
Nilsson, L.6
Larsson, K.7
Borsodi, A.8
Toth, G.9
Hill, R.10
Kitchen, I.11
Pintar, J.E.12
-
23
-
-
13444302513
-
Autoradiography in opioid triple knockout mice reveals opioid and opioid receptor like binding of naloxone benzoylhydrazone
-
Cox V, Clarke S, Czyzyk T, Ansonoff M, Nitsche J, Hsu MS, Borsodi A, Tomboly C, Toth G, Hill R, Pintar J, Kitchen I: Autoradiography in opioid triple knockout mice reveals opioid and opioid receptor like binding of naloxone benzoylhydrazone. Neuropharmacology 2005; 48:228-35
-
(2005)
Neuropharmacology
, vol.48
, pp. 228-235
-
-
Cox, V.1
Clarke, S.2
Czyzyk, T.3
Ansonoff, M.4
Nitsche, J.5
Hsu, M.S.6
Borsodi, A.7
Tomboly, C.8
Toth, G.9
Hill, R.10
Pintar, J.11
Kitchen, I.12
-
24
-
-
0002261078
-
A method for determining loss of pain sensation
-
D'Amour FE, Smith DL: A method for determining loss of pain sensation J Pharmacol Exp Ther 1941; 72:74-9
-
(1941)
J Pharmacol Exp Ther
, vol.72
, pp. 74-79
-
-
D'Amour, F.E.1
Smith, D.L.2
-
25
-
-
0021034832
-
Daily rhythms of analgesia in mice: Effects of age and photoperiod
-
Kavaliers M, Hirst M: Daily rhythms of analgesia in mice: Effects of age and photoperiod. Brain Res 1983; 279:387-93
-
(1983)
Brain Res
, vol.279
, pp. 387-393
-
-
Kavaliers, M.1
Hirst, M.2
-
26
-
-
0029812270
-
The effects of pain on opioid tolerance: How do we resolve the controversy?
-
Gutstein HB: The effects of pain on opioid tolerance: How do we resolve the controversy? Pharmacol Rev 1996; 48:403-7
-
(1996)
Pharmacol Rev
, vol.48
, pp. 403-407
-
-
Gutstein, H.B.1
-
27
-
-
0345550293
-
Opioid hyperalgesia and tolerance versus 5-HT1a receptor-mediated inverse tolerance
-
Xu X-J, Colpaert F, Wiesenfield-Hallin Z: Opioid hyperalgesia and tolerance versus 5-HT1a receptor-mediated inverse tolerance. Trends Pharmacol Sci 2003;24:634-9
-
(2003)
Trends Pharmacol Sci
, vol.24
, pp. 634-639
-
-
Xu, X.-J.1
Colpaert, F.2
Wiesenfield-Hallin, Z.3
-
28
-
-
2442503913
-
Modulation of morphine analgesia by site-specific A-methyl-D-aspartate receptor antagonists: Dependence on sex, site of antagonism, morphine dose, and time
-
Nemmani KV, Gisel JE, Stowe JR, Smith-Carliss R, Mogil JS: Modulation of morphine analgesia by site-specific A-methyl-D-aspartate receptor antagonists: Dependence on sex, site of antagonism, morphine dose, and time. Pain 2004; 109:274-83
-
(2004)
Pain
, vol.109
, pp. 274-283
-
-
Nemmani, K.V.1
Gisel, J.E.2
Stowe, J.R.3
Smith-Carliss, R.4
Mogil, J.S.5
-
29
-
-
21744446440
-
Alfentanil and placebo analgesia: No sex differences detected in models of experimental pain
-
Olofsen E, Romberg R, Bijl H, Mooren R, Engbers F, Kest B, Dahan A: Alfentanil and placebo analgesia: No sex differences detected in models of experimental pain. ANESTHESIOLOGY 2005; 103:130-9
-
(2005)
ANESTHESIOLOGY
, vol.103
, pp. 130-139
-
-
Olofsen, E.1
Romberg, R.2
Bijl, H.3
Mooren, R.4
Engbers, F.5
Kest, B.6
Dahan, A.7
-
30
-
-
0035967934
-
Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats
-
Kozela Danysz W, Popik P: Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. Eur J Pharmacol 2001; 423:17-26
-
(2001)
Eur J Pharmacol
, vol.423
, pp. 17-26
-
-
Kozela Danysz, W.1
Popik, P.2
-
31
-
-
33746932120
-
-
van Dorp E, Yassen A, Sarton E, Romberg R, Olofsen E, TeppemaL, Danhof M, Dahan A: Naloxone reversal of buprenorphine-induced respiratory depression. ANESTHESIOLOGY 2006; 105:51-7
-
van Dorp E, Yassen A, Sarton E, Romberg R, Olofsen E, TeppemaL, Danhof M, Dahan A: Naloxone reversal of buprenorphine-induced respiratory depression. ANESTHESIOLOGY 2006; 105:51-7
-
-
-
-
32
-
-
35148843746
-
Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone: A study in healthy volunteers
-
Yassen A, Olofsen E, van Dorp E, Sarton E, Teppema L, Danhof M, Dahan A: Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone: A study in healthy volunteers. Clin Pharmacokinet 2007; 46:965-80
-
(2007)
Clin Pharmacokinet
, vol.46
, pp. 965-980
-
-
Yassen, A.1
Olofsen, E.2
van Dorp, E.3
Sarton, E.4
Teppema, L.5
Danhof, M.6
Dahan, A.7
-
33
-
-
33847202553
-
A randomized, double-blind, placebo controlled pilot study of iv morphine-6- glucuronide for postoperative pain relief after knee replacement surgery
-
Romberg R, van Dorp E, Hollander J, Kruit M, Binning A, Smith T, Dahan A: A randomized, double-blind, placebo controlled pilot study of iv morphine-6- glucuronide for postoperative pain relief after knee replacement surgery. Clin J Pain 2007; 23:197-203
-
(2007)
Clin J Pain
, vol.23
, pp. 197-203
-
-
Romberg, R.1
van Dorp, E.2
Hollander, J.3
Kruit, M.4
Binning, A.5
Smith, T.6
Dahan, A.7
-
34
-
-
0033756927
-
-
Sarton E, Olofsen E, Romberg R, den HartighJ, Kest B, Nieuwenhuijs D, Burm A, Teppema L, Dahan A: Sex difference in opioid analgesia: An experimental study in healthy volunteers. ANESTHESIOLOGY 2000; 93:1245-54
-
Sarton E, Olofsen E, Romberg R, den HartighJ, Kest B, Nieuwenhuijs D, Burm A, Teppema L, Dahan A: Sex difference in opioid analgesia: An experimental study in healthy volunteers. ANESTHESIOLOGY 2000; 93:1245-54
-
-
-
-
35
-
-
0028226888
-
The excitatory effects of morphine-3- glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex
-
Bartlett SE, Cramond T, Smith MT: The excitatory effects of morphine-3- glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sci 1994; 54:687-94
-
(1994)
Life Sci
, vol.54
, pp. 687-694
-
-
Bartlett, S.E.1
Cramond, T.2
Smith, M.T.3
-
36
-
-
0025830147
-
Mu receptor binding of some commonly used opioids and their metabolites
-
Chen ZR, Irvine JR, Somogyi AA, Bochner F: Mu receptor binding of some commonly used opioids and their metabolites. Life Sci 1991; 48:2165-71
-
(1991)
Life Sci
, vol.48
, pp. 2165-2171
-
-
Chen, Z.R.1
Irvine, J.R.2
Somogyi, A.A.3
Bochner, F.4
-
37
-
-
0034522785
-
Randomized placebo-controlled trial of the activity of the morphine glucuronides
-
Penson RT, Joel SP, Bakhshi K, Clark SJ, Langford RM, Slevin ML: Randomized placebo-controlled trial of the activity of the morphine glucuronides. Clin Pharmacol Ther 2000; 68:667-76
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 667-676
-
-
Penson, R.T.1
Joel, S.P.2
Bakhshi, K.3
Clark, S.J.4
Langford, R.M.5
Slevin, M.L.6
-
38
-
-
0035157740
-
Limited phase I study of morphine-3-glucuronide
-
Penson RT, Joel SP, Clark S, Gloyne A, Slevin ML: Limited phase I study of morphine-3-glucuronide. J Pharm Sci 2001; 90:1810-6
-
(2001)
J Pharm Sci
, vol.90
, pp. 1810-1816
-
-
Penson, R.T.1
Joel, S.P.2
Clark, S.3
Gloyne, A.4
Slevin, M.L.5
-
39
-
-
0037369176
-
Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: Theory and clinical reality, part 1. Psychosomatics2003
-
Armstrong SC, Cozza KL: Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: Theory and clinical reality, part 1. Psychosomatics2003; 44:167-71
-
, vol.44
, pp. 167-171
-
-
Armstrong, S.C.1
Cozza, K.L.2
-
40
-
-
21044435938
-
Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and decreased antinociception by morphine-6-glucuronide
-
Zelcer N, van de Wetering K, Hillebrand M, Sarton E, Kuil A, Wielinga PR, Tephly T, Dahan A, Beijnen JH, Borst P: Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and decreased antinociception by morphine-6-glucuronide. Proc Natl Acad Sci USA 2005; 102:7274-9
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 7274-7279
-
-
Zelcer, N.1
van de Wetering, K.2
Hillebrand, M.3
Sarton, E.4
Kuil, A.5
Wielinga, P.R.6
Tephly, T.7
Dahan, A.8
Beijnen, J.H.9
Borst, P.10
-
41
-
-
0042463635
-
Morphine-3-glucuronide's neuroexcitatory effects are mediated via indirect activation of N-methyl-D-aspar- tic acid receptors: Mechanistic studies in embryonic cultured hippocampal neurons
-
Hemstapat K, Monteith GR, Smith D, Smith MT: Morphine-3-glucuronide's neuroexcitatory effects are mediated via indirect activation of N-methyl-D-aspar- tic acid receptors: Mechanistic studies in embryonic cultured hippocampal neurons. Anesth Analg 2003; 97:494-505
-
(2003)
Anesth Analg
, vol.97
, pp. 494-505
-
-
Hemstapat, K.1
Monteith, G.R.2
Smith, D.3
Smith, M.T.4
-
42
-
-
0018367544
-
Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity
-
Labella FS, Pinsky C, Havlicek V: Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity. Brain Res 1979; 174:263-71
-
(1979)
Brain Res
, vol.174
, pp. 263-271
-
-
Labella, F.S.1
Pinsky, C.2
Havlicek, V.3
-
43
-
-
0347363517
-
-
Romberg R, Olofsen E, Sarton E, den HartighJ, Taschner PEM, Dahan A: Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-in- duced analgesia in healthy volunteers. ANESTHESIOLOGY 2004; 100:120-33
-
Romberg R, Olofsen E, Sarton E, den HartighJ, Taschner PEM, Dahan A: Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-in- duced analgesia in healthy volunteers. ANESTHESIOLOGY 2004; 100:120-33
-
-
-
-
44
-
-
14644441712
-
Polymorphism of uμ-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response
-
Romberg RR, Olofsen E, Bijl H, Taschner PEM, Teppema LJ, Sarton EY, van Kleef J, Dahan A: Polymorphism of uμ-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. ANESTHESIOLOGY 2005; 102:522-30
-
(2005)
ANESTHESIOLOGY
, vol.102
, pp. 522-530
-
-
Romberg, R.R.1
Olofsen, E.2
Bijl, H.3
Taschner, P.E.M.4
Teppema, L.J.5
Sarton, E.Y.6
van Kleef, J.7
Dahan, A.8
-
45
-
-
33747728423
-
-
5th edition. Edited by McMahon SB, Koltzenberg M. Amsterdam, Elsevier
-
Gracely RH: Studies of pain in human subjects, Wall and Melzack's Textbook of Pain, 5th edition. Edited by McMahon SB, Koltzenberg M. Amsterdam, Elsevier, 2006, pp 267- 89
-
(2006)
Studies of pain in human subjects, Wall and Melzack's Textbook of Pain
, pp. 267-289
-
-
Gracely, R.H.1
-
46
-
-
0035193561
-
The involvement of the uμ-opioid receptor in ketamine-induced respiratory depression and antinociception
-
Sarton E, Teppema L, Olievier CN, Nieuwenhuijs D, Matthes HWD, Kieffer BL, Dahan A: The involvement of the uμ-opioid receptor in ketamine-induced respiratory depression and antinociception. Anesth Analg 2001; 93:1495-500
-
(2001)
Anesth Analg
, vol.93
, pp. 1495-1500
-
-
Sarton, E.1
Teppema, L.2
Olievier, C.N.3
Nieuwenhuijs, D.4
Matthes, H.W.D.5
Kieffer, B.L.6
Dahan, A.7
|